CONFALONIERI, Marco
 Distribuzione geografica
Continente #
NA - Nord America 10.768
EU - Europa 8.069
AS - Asia 3.073
SA - Sud America 109
AF - Africa 62
OC - Oceania 54
Continente sconosciuto - Info sul continente non disponibili 13
Totale 22.148
Nazione #
US - Stati Uniti d'America 10.654
IT - Italia 1.933
RU - Federazione Russa 1.715
PL - Polonia 1.519
HK - Hong Kong 927
CN - Cina 856
SE - Svezia 797
TR - Turchia 468
SG - Singapore 378
UA - Ucraina 353
DE - Germania 351
BG - Bulgaria 334
IE - Irlanda 306
GB - Regno Unito 157
FR - Francia 119
FI - Finlandia 115
IN - India 91
VN - Vietnam 83
CH - Svizzera 80
KR - Corea 68
BE - Belgio 61
CA - Canada 56
MX - Messico 53
ES - Italia 49
AU - Australia 46
IR - Iran 38
JP - Giappone 38
TW - Taiwan 37
BR - Brasile 36
NL - Olanda 34
SN - Senegal 29
AT - Austria 24
CO - Colombia 23
CZ - Repubblica Ceca 18
CL - Cile 17
PK - Pakistan 17
GR - Grecia 16
PT - Portogallo 15
NO - Norvegia 14
RO - Romania 14
EU - Europa 13
AR - Argentina 12
EG - Egitto 11
IL - Israele 10
PE - Perù 10
HR - Croazia 9
RS - Serbia 9
EC - Ecuador 8
MY - Malesia 8
NZ - Nuova Zelanda 8
SA - Arabia Saudita 8
TH - Thailandia 8
DK - Danimarca 7
ID - Indonesia 7
PH - Filippine 7
ZA - Sudafrica 7
BD - Bangladesh 6
LT - Lituania 6
HU - Ungheria 4
JO - Giordania 4
SI - Slovenia 4
TN - Tunisia 4
CM - Camerun 3
MD - Moldavia 3
NI - Nicaragua 3
YE - Yemen 3
AE - Emirati Arabi Uniti 2
DZ - Algeria 2
ET - Etiopia 2
KW - Kuwait 2
MA - Marocco 2
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BY - Bielorussia 1
BZ - Belize 1
CI - Costa d'Avorio 1
GL - Groenlandia 1
KE - Kenya 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
PS - Palestinian Territory 1
UY - Uruguay 1
VE - Venezuela 1
Totale 22.148
Città #
Moscow 1.630
Warsaw 1.510
Fairfield 1.433
Chandler 1.005
Hong Kong 906
Woodbridge 882
Ashburn 822
Wilmington 795
Houston 695
Seattle 637
Princeton 516
Cambridge 505
Ann Arbor 482
Trieste 469
Jacksonville 421
Izmir 389
Sofia 331
Dublin 284
Wellsboro 275
Beijing 250
Singapore 198
Boardman 107
Milan 107
San Diego 106
Redwood City 85
Redmond 78
Dong Ket 71
Dearborn 64
Helsinki 62
Rome 62
Columbus 57
Seoul 55
Bern 51
Brussels 50
Dongguan 48
Norwalk 47
Kocaeli 40
Bremen 37
Los Angeles 37
Phoenix 36
Venezia 35
Cividale del Friuli 32
Jinan 30
Dakar 29
Naples 29
Udine 29
Lappeenranta 28
Guangzhou 27
Pune 27
Shanghai 27
Boydton 25
Grafing 25
Buffalo 23
Paris 23
Des Moines 22
Florence 22
Turin 22
Falls Church 21
Fremont 20
Nanjing 20
Bari 19
Istanbul 19
London 19
Washington 19
Chicago 18
Hefei 18
Arzene 16
New York 16
Taipei 16
Torre Del Greco 16
Vienna 16
Bologna 15
Toronto 15
Tucson 15
Sydney 14
Zhengzhou 14
Duino-Aurisina 13
Brescia 12
Fuzhou 12
Kunming 12
Shenyang 12
Tokyo 12
Barcelona 11
Fagagna 11
La Spezia 11
Tappahannock 11
Brno 10
Brooklyn 10
Buenos Aires 10
Central 10
Chengdu 10
Council Bluffs 10
Hebei 10
Treviso 10
Vancouver 10
Berlin 9
Centro 9
Melbourne 9
Obregon 9
San Francisco 9
Totale 16.668
Nome #
Metabolic exercise test data combined with cardiac and kidney indexes, the MECKI score: A multiparametric approach to heart failure prognosis. 1.728
Keratin14 mRNA expression in human pneumocytes during quiescence, repair and disease 374
The Time to Offer Treatments for COVID-19 346
Alpha-1 antitrypsin deficiency as a common treatable mechanism in chronic respiratory disorders and for conditions different from pulmonary emphysema? A commentary on the new European Respiratory Society statement 325
Acute respiratory distress syndrome 316
Complement Protein C1q binds to Hyaluronic Acid in the Malignant Pleural Mesothelioma Microenvironment and Promotes Tumour Growth 283
miR-200 family members reduce senescence and restore idiopathic pulmonary fibrosis type II alveolar epithelial cell transdifferentiation 263
Epithelial⁻Mesenchymal Transition in the Pathogenesis of Idiopathic Pulmonary Fibrosis 250
Practical recommendations for diagnosis and management of respiratory muscle weakness in late-onset Pompe disease 240
Pregnancy in patients with tuberculosis: A TBNET cross-sectional survey 234
Respiratory muscle training with enzyme replacement therapy improves muscle strength in late - onset Pompe disease. 234
Is early detection of late-onset Pompe disease a pneumologist’s affair? A lesson from an Italian screening study 228
Evaluation of the Interplay Between the Complement Protein C1q and Hyaluronic Acid in Promoting Cell Adhesion 222
Deep sedation versus minimal sedation during endobronchial ultrasound transbronchial needle aspiration 216
A retrospective study of endobronchial ultrasound transbronchial needle aspiration versus conventional transbronchial needle aspiration in diagnosis/staging of hilar/mediastinal lymph node in lung cancer: Which role in clinical practice? 213
Effect of cystic fibrosis sputum rheology on lungs drug delivery by inhalation 211
Tumour infiltrating lymphocytes and PD-L1 expression as potential predictors of outcome in patients with malignant pleural mesothelioma 199
Epidemiology of Tuberculosis and the Rise of XDR-TB 162
The Importance of Understanding the Stages of COVID-19 in Treatment and Trials 162
null 161
A novel approach based on low-field NMR for the detection of the pathological components of sputum in cystic fibrosis patients 161
High-frequency percussive ventilation improves perioperatively clinical evolution in pulmonary resection 160
High-throughput screening discovers antifibrotic properties of haloperidol by hindering myofibroblast activation 159
Keratin-14 expression in pneumocytes as a marker of lung regeneration/repair during diffuse alveolar damage 155
Nailfold Capillaroscopy Characteristics of Antisynthetase Syndrome and Possible Clinical Associations: Results of a Multicenter International Study 155
Aspiration Risk Factors, Microbiology, and Empiric Antibiotics for Patients Hospitalized With Community-Acquired Pneumonia 153
Corticosteroids do not cause harmful increase of viral load in severe H1N1 virus infection. 150
Herpes simplex virus (HSV) pneumonia in the non-ventilated immunocompromised host: Burden and predictors 147
The prognostic role of Gender-Age-Physiology system in idiopathic pulmonary fibrosis patients treated with pirfenidone 146
A Multicenter Study of Post-COVID-19 Interstitial Lung Syndrome 146
Can low field nuclear magnetic resonance be used to monitor lung functionality of cystic fibrosis patients? 145
Heart failure prognosis over time: how the prognostic role of oxygen consumption and ventilatory efficiency during exercise has changed in the last 20 years 141
Towards synchrotron phase-contrast lung imaging in patients - a proof-of-concept study on porcine lungs in a human-scale chest phantom. 135
An adalimumab-induced late-onset immune reconstitution inflammatory syndrome treated with adalimumab 132
Alveolar Epithelial Type II Cells 132
Left ventricular thrombectomy in myocarditis: the epicardial scan & video-assisted transaortic approach 125
Role of the complement protein C1q in the regulation of hyaluronic acid cleavage in malignant pleural mesothelioma 125
Sildenafil in pulmonary arterial hypertension. 124
Prognostic value of cardiopulmonary exercise testing in Idiopathic Dilated Cardiomyopathy 124
Acute respiratory failure in patients with severe community-acquired pneumonia: A prospective randomized evaluation of noninvasive ventilation 124
Sildenafil in severe pulmonary hypertension associated with chronic obstructive pulmonary disease: A randomized controlled multicenter clinical trial 120
The value and scope of subspecialty biomedical journals: Perspectives from either side of the Atlantic. 118
Potential links between COVID-19-associated pulmonary aspergillosis and bronchiectasis as detected by high resolution computed tomography 118
Increased number and expertise of Italian respiratory high-dependency care units: The second national survey 112
A novel approach based on low field nuclear magnetic resonance for the detection of the pathological components of the sputum of cystic fibrosis patients 111
Accuracy of right atrial pressure estimation using a multi-parameter approach derived from inferior vena cava semi-automated edge-tracking echocardiography: a pilot study in patients with cardiovascular disorders 111
Can rheology be useful in the cystic fibrosis frame 110
Functional Progression in Patients with Interstitial Lung Disease Resulted Positive to Antisynthetase Antibodies: A Multicenter, Retrospective Analysis 110
Documento AIPO-SIMeR sulla Fibrosi Polmonare Idiopatica 109
Effectiveness of a bronchial drainage technique (ELTGOL) in COPD exacerbations 107
Costs of the COPD. Differences between intensive care unit and respiratory intermediate care unit 107
Anemia and health performance score evaluation as decisive factors for noninvasive mechanical ventilation decisions in AECOPD: Are there new key cornerstones? 106
Influence of various therapeutic strategies on right ventricular morphology, function and hemodynamics in pulmonary arterial hypertension 106
Burden of chronic obstructive pulmonary disease 106
Radiological-pathological signatures of patients with COVID-19-related pneumomediastinum: is there a role for the Sonic hedgehog and Wnt5a pathways? 106
Hydrocortisone infusion for severe community-acquired pneumonia: A preliminary randomized study 104
Timing of onset affects arthritis presentation pattern in antisyntethase syndrome 102
COMPLEMENT PROTEIN C1Q PRODUCTION IN MALIGNANT PLEURAL MESOTHELIOMA 101
Long-term azithromycin use in patients with chronic obstructive pulmonary disease and tracheostomy 100
Comorbidities, Cardiovascular Therapies, and COVID-19 Mortality: A Nationwide, Italian Observational Study (ItaliCO) 97
The appropriate setting of noninvasive pressure support ventilation in stable COPD patients 96
C1q–Ha matrix regulates the local synthesis of hyaluronan in malignant pleural mesothelioma by modulating has3 expression 94
Efficacy and safety of azithromycin 1 g once daily for 3 days in the treatment of community-acquired pneumonia: An open-label randomised comparison with amoxicillin-clavulanate 875/125 mg twice daily for 7 days 93
Prolonged hospitalisation for immigrants and high risk patients with positive smear pulmonary tuberculosis 92
Il supporto decisionale nei processi di acquisto dei broncoscopi monouso 92
Corticosteroid treatment in severe community-acquired pneumonia: Duration of treatment affects control of systemic inflammation and clinical improvement 91
Inspiratory muscle training for diaphragm dysfunction after cardiac surgery 90
Corticosteroids in the treatment of severe sepsis and septic shock in adults: A systematic review 90
Approccio pragmatico alla diagnosi di polmonite da SARS-CoV-2 (COVID-19). Dalla fase epidemica alle fasi due e tre. 90
Opening of a respiratory intermediate care unit in a general hospital: Impact on mortality and other outcomes 89
Italian registry of patients with alpha-1 antitrypsin deficiency: General data and quality of life evaluation 87
To use or not to use corticosteroids for pneumonia? A clinician's perspective 87
Reliability of noninvasive hemodynamic assessment with Doppler echocardiography: comparison with the invasive evaluation 87
Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study 87
Bosentan for patients with chronic thromboembolic pulmonary hypertension 86
Emergency Laser Treatment of a Tracheobronchial Carcinoid during ECMO 85
Low sensitivity of rapid tests detecting anti-CoV-2 IgG and IgM in health care workers’ serum for COVID-19 screening 85
Efficacy of pirfenidone for idiopathic pulmonary fibrosis: An Italian real life study 84
Predictors of failure of noninvasive positive pressure ventilation in patients with acute hypoxemic respiratory failure: A multi-center study 84
Limited role for bronchoalveolar lavage to exclude Covid-19 after negative upper respiratory tract swabs: a multicenter study 84
Interstitial lung disease in patients with antisynthetase syndrome: a retrospective case series study 84
A chart of failure risk for noninvasive ventilation in patients with COPD exacerbation 83
Monitoring sputum properties in cystic fibrosis patients by means of Low-Field NMR before after kaftrio treatment 82
Noninvasive ventilation 82
Inhaled corticosteroids reduce neutrophilic bronchial inflammation in patients with chronic obstructive pulmonary disease 81
The effectiveness of a bronchial drainage technique (ELTGOL) in COPD exacerbations 81
Tuberculosis screening in outpatient healthcare workers: lessons from a high-income, low TB burden country 81
Use of Rheology and portable Low-Field NMR for the monitoring of lung functions in cystic fibrosis patients 80
Use of low field nuclear magnetic resonance to monitor lung inflammation and the amount of pathological components in the sputum of cystic fibrosis patients 79
The Treatment of Lung Involvement in Systemic Sclerosis 79
Histoplasmosis capsulati in Italy: Autochthonous or imported? 77
Children under 5 years are at risk for tuberculosis after occasional contact with highly contagious patients: outbreak from a smear-positive healthcare worker 76
The role of respiratory management of Pompe disease 76
Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials 76
Out-patient high-dose-rate endobronchial brachytherapy for palliation of lung cancer: An observational study 76
Respiratory intensive care units in Italy: A national census and prospective cohort study 76
Evolution of Programmatic Definitions Used inTuberculosis Prevention and Care 76
Severity of lung involvement on chest X-rays in SARS-coronavirus-2 infected patients as a possible tool to predict clinical progression: an observational retrospective analysis of the relationship between radiological, clinical, and laboratory data 76
Effect of chest physiotherapy on cystic fibrosis sputum nanostructure: an experimental and theoretical approach 76
Glucocorticoid treatment in community-acquired pneumonia 75
Totale 14.712
Categoria #
all - tutte 75.161
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 75.161


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.955 0 184 179 756 342 471 460 379 405 328 256 195
2020/20213.120 306 197 164 343 217 232 252 330 199 396 141 343
2021/20223.205 162 240 142 239 107 187 202 144 464 319 302 697
2022/20234.120 430 488 373 472 339 654 104 309 434 66 286 165
2023/20244.443 175 153 231 183 275 447 585 770 106 227 752 539
2024/20251.043 898 145 0 0 0 0 0 0 0 0 0 0
Totale 23.225